Charles is an M.D. Ph.D. with specializations in internal medicine, oncology and haematology. After a 2 year post-doctoral fellowship in Stanford Medical School he created his research team and is now Principal Investigator. of the Anticancer Antibody team at the CRCL, Lyon.
He has performed animal experimentation for over 20 years and conducted a variety of translational research projects as well as drug development trials in haematology and solid tumours.
He also teaches haematology for medical students and coordinates a master’s program in cancer research at the University Claude Bernard Lyon 1.
He is deputy director of the Cancer Research Centre of Lyon, of the translational research programme LYRIC (coordinator Pr Jean Yves Blay) and of the Fédération Hospitalo-Universitaire DIPOHL (Pr Gilles Salles, HCL). He is the chair of the Hospices Civils de Lyon Research Council.
Thanks to his clinical and preclinical expertise, Charles advises Antineo customers for their preclinical and clinical development program.